Challenges and opportunities associated with the introduction of next-generation long-lasting insecticidal nets for malaria control: a case study from Burkina Faso by unknown
RESEARCH Open Access
Challenges and opportunities associated
with the introduction of next-generation
long-lasting insecticidal nets for malaria
control: a case study from Burkina Faso
Kemi Tesfazghi1, Adama Traore2, Hilary Ranson1, Sagnon N’Fale2, Jenny Hill3 and Eve Worrall1*
Abstract
Background: Reductions in malaria incidence in Africa can largely be attributed to increases in malaria vector
control activities; predominately the use of long-lasting insecticidal nets (LLINs). With insecticide resistance affecting
an increasing number of malaria-endemic countries and threatening the effectiveness of conventional LLINs, there
is an increasing urgency to implement alternative tools that control these resistant populations. The aim of this
study was to identify potential challenges and opportunities for accelerating access to next-generation LLINs in
Burkina Faso, a country with areas of high levels of insecticide resistance.
Methods: An analytical framework was used to guide the selection of interviewees, data collection and analysis.
Semi-structured interviews were carried out with key informants in April 2014 in Burkina Faso. Interviews were
conducted in French and English, audio recorded, transcribed and entered into NVivo 10 for data management and
analysis. Data were coded according to the framework themes and then analysed to provide a description of the
key points and explain patterns in the data.
Results: Interviewees reported that the policy architecture in Burkina Faso is characterised by a strong framework
of actors that contribute to policymaking and strong national research capacity which indirectly contributes to
national policy change via collaboration with internationally led research. Financing significantly impacts the
potential adoption, availability and affordability of next-generation LLINs. This confers significant power on
international donors that fund vector control. National decisions around which LLINs to procure were restricted to
quantity and delivery dates; the potential to tackle insecticide resistance was not part of the decision-making
process. Furthermore, at the time of the study, there was no World Health Organization (WHO) guidance on where
and when next-generation LLINs might positively impact on malaria transmission, severely limiting their adoption,
availability and affordability.
Conclusions: This study shows that access to next-generation LLINs was severely compromised by the lack of
global guidance. In a country like Burkina Faso where WHO recommendations are relatively quickly adopted, a clear
WHO recommendation and adequate financing will be key to accelerate access to next-generation LLINs.
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Background
Reductions in malaria incidence in Africa are largely at-
tributable to improved vector control, predominately the
use of long-lasting insecticidal nets (LLINs), indoor re-
sidual spraying (IRS) and, to a lesser extent, larval source
management (LSM) [1, 2]. LLINs are one of the most
cost-effective measures against malaria [3, 4], with World
Health Organization (WHO) recommending universal
coverage with LLINs (defined as universal access and use)
for all people at risk of malaria [5]. Currently, pyrethroids
are the only class of insecticide approved for use on
LLINs, and therefore the rapid increase in mosquito re-
sistance to pyrethroids represents a serious concern [1, 6].
The loss of LLIN effectiveness would be catastrophic, jeo-
pardising the ability to achieve malaria control and elimin-
ation goals [7].
Insecticide resistance management strategies and alter-
natives to conventional LLINs need to be implemented.
One option is to provide access to ‘next-generation
LLINs’ treated with two or more insecticides (combin-
ation LLINs), or with an insecticide and the synergist
piperonyl butoxide (PBO LLINs), designed to be more
effective against pyrethroid-resistant vectors. Access to
new LLINs requires the ability to acquire and use them.
In this study we adopt the Frost and Reich view that ac-
cess is a series of logistical, economic and political pro-
cesses that affect acquisition and use [8].
Two PBO LLINs (PermaNet© 3.0 and Olyset Plus©) are
currently available on the market after receiving WHOPES
interim approval as standard LLINs in 2008 and 2012, re-
spectively [9, 10]. In 2014, the WHO Vector Control Ad-
visory Group, whose remit is to advise WHO on new
forms of vector control, recognised PermaNet© 3.0 as hav-
ing ‘increased bio-efficacy’ compared to pyrethroid-only
LLINs in areas of insecticide resistance [11]. Recom-
mendations for evaluating next-generation nets have
recently been published [11], but at the time the study
was conducted, there were no normative guidelines on
when and where these should be deployed. Burkina
Faso is one the few countries where a PBO LLIN was
deployed as part of a national campaign in 2010 and
2013 [12].
We conducted an analysis of the context, content, pro-
cesses, actors, power and role of evidence in malaria vec-
tor control policymaking in Burkina Faso and of the
decision to deploy PBO LLINs in a national campaign in
Burkina Faso. The study aims to identify potential chal-
lenges and opportunities for accelerating access to new
vector control tools in Burkina Faso.
Methods
Study site
Insecticide resistance is widespread in Burkina Faso [13]
and, in the southwestern region of the country, the high
level of resistance is reducing the activity of insecticides
on conventional LLINs [14]. Furthermore, despite two
LLIN distribution rounds in 2010 and 2013, and over
70 % of children under the age of 5 years reportedly
sleeping under LLINs [15, 16], the national prevalence of
Plasmodium falciparum was 61 % in children aged
6 months to 5 years in 2014 [16]. Detailed follow-up
studies in different regions of the country have found no
reduction in malaria rates following the 2010 distribu-
tion programme [17, 18]. It has recently been confirmed
that a third of the nets procured by Le Programme
d’Appui au Développement Sanitaire (PADS, the pro-
curement department of the Ministry of Health) for
the 2010 distribution were counterfeit, non-WHO Pesticide
Evaluation Scheme (WHOPES)-approved LLINs, packaged
as genuine WHOPES-approved LLINs [19]. The Global
Fund to Fight AIDS, Tuberculosis and Malaria (GFATM)
Office of the Inspector General has highlighted significant
weaknesses in the procurement process for the 2010 cam-
paign. These weaknesses were exploited by two suppliers
who provided almost 2.7 million nets that were not prop-
erly treated with insecticide and reportedly caused side ef-
fects to recipients [19]. At the time the interviews for this
study were conducted, knowledge of this fraud was not in
the public domain and the study team was not aware of it.
Approximately 1.6 million (20 %) of the LLINs distributed
in 2010 were a PBO LLIN, PermaNet© 3.0 (H Pates Jamet,
Vestergaard Frandsen, personal communication), but there
was no accompanying monitoring and evaluation plan to
compare the efficacy of the PBO LLINs with conventional
LLINs.
Analytical framework
The modified analytical framework comprised of seven
themes derived from all five concepts (actors, power,
context, content and process) in the Walt and Gilson
policy analysis framework [20], with two additional
themes, availability and affordability, from the four
themes in the Frost and Reich framework [8] (Table 1).
Given that the ‘policy’ under review relates to the
introduction of a malaria vector control tool, the
themes of availability and affordability (not contained
in the Walt and Gilson framework) are important.
The themes of architecture and adoption from the
Frost and Reich framework are the equivalent of the
actors and process themes in the Walt and Gilson
framework.
The modified framework was used to guide the selec-
tion of relevant policy stakeholder groups for interview,
develop themes for the semi-structured interview guide,
and for data analysis. For the purposes of this study, the
definition of policy extends beyond a broad statement of
goals [21] to include individual aspects of a policy such
as the use of a specific tool [22].
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Desk review
In March 2014 and March 2015, PubMed-MEDLINE,
Web of Science, Global Health, Jstor and Taylor & Francis
were searched for peer-reviewed literature using the fol-
lowing search terms: ‘Burkina Faso’, ‘malaria’, ‘malaria con-
trol’, ‘malaria prevention’, ‘vector control’, ‘policymaking’, ‘policy
analysis’, ‘decision-making’ and ‘evidence-based policy’.
In addition, using the same terms, Google, Google
Scholar, the Programme National de Lutte Contre le
Paludisme (PNLP) website, as well as partners’ websites,
were searched for relevant reports, strategies, policies
and meeting minutes. The purpose of the desk review
was to identify the key actors (institutions and individ-
uals) involved in national vector control for interview, to
refine the research question and semi-structured inter-
view guide, and to supplement findings from these.
Study participants
The identification of the study participants was a two-
step process. Using the literature and the local know-
ledge of two Burkinabe collaborators (Mr. Traore and
Dr. N’Fale), institutions that participated in national
malaria vector control policymaking were identified. An
initial list of 15 institutions was drawn up and one per-
son from each was contacted to request participation.
The most senior person tasked with LLIN policy, imple-
mentation, procurement and research or funding were
considered to be potential interviewees. One additional
interviewee was identified during the interviewing process.
Interviewees were categorised into six groups: policy-
makers—staff of the Ministry of Health (MoH) working
as part of the PNLP; implementers—working for non-
governmental organisations (NGOs) to implement mal-
aria control projects; multilaterals—employees of United
Nations technical agencies supporting malaria control;
donors—including employees of organisations that finance
and procure malaria control tools; researchers—those
working in academia/national institutes of research; and
private sector—those in the commercial for-profit sector
involved in the sale of vector control tools and insecticide
products. While the sample size was guided by feasibility,
interviewees were selected to encompass viewpoints from
all six categories.
Semi-structured interviews
Interviews were carried out in April 2014 in Ouagadougou,
Burkina Faso. All interviews were conducted by the lead
researcher and Mr Traore; 12 of the 13 interviews were
conducted in French by Mr. Traore and one in English by
the lead researcher. The interviewers jointly reviewed the
first four interviews conducted to establish consistency in
data collection. The interviews followed a semi-structured,
open-ended format, which was developed in English and
subsequently translated into French (Additional file 1).
The semi-structured interview guide included ques-
tions on who was involved in the policymaking process;
who carried the most influence and why; how vector
control policies were made (including the role of evi-
dence); and factors that influenced the availability and
affordability of PBO LLINs.
All interviewees gave signed consent for participating
in the audio-recorded interviews and for the use of an-
onymous quotes. In reporting quotes, interviewees’ roles
(e.g. policymaker) are disclosed to highlight their perspec-
tive. Ethical clearance was obtained from ethics com-
mittees at Liverpool School of Tropical Medicine and
Burkina Faso (Additional file 2).
Data analysis
Translated and accuracy-checked transcripts were entered
into NVivo 10 for data management and analysis through
the following four steps: (i) familiarisation (reading of
transcripts); (ii) coding data according to themes in analyt-
ical framework; (iii) summarising data by interviewee and
themes; and (iv) synthesis of the key points in each theme
and exploration of patterns in the data.
Table 1 Framework used for sampling, interview guide and data analysis
Definition (adapted from Walt and Gilson unless otherwise indicated)
1 Context The systemic factors such as—political system, type of economy, employment base, national and international actions/
cooperation—which may have an effect on health policy.
2 Content The content of the policy, which reflects the output of the interplay between actors, processes and context.
3 Actors The network of institutions and individuals that influence the adoption of a new policy
4 Power The ability to influence, and in particular to control, resources.
It can be seen in a number of dimensions including decision-making [23], agenda setting [24], thought control [25],
control of financial resources and access to/level of knowledge [22].
5 Policy adoption process The way in which policies are made, i.e. initiated, developed/negotiated/formulated/endorsed. In this study, this includes
the use of evidence in the policymaking process.
6 Availability In this study, we restrict consideration of availability to ordering (i.e. choosing and procuring a next-generation LLIN).
(Frost and Reich)
7 Affordability Involves the willingness to pay for (finance) a next-generation LLIN by global organisations as they are the primary
donors of vector control. (Frost and Reich)
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Results
A total of 13 people were interviewed: two researchers,
four policymakers, three implementers, two donors, and
two multilateral agencies. Three potential interviewees
(one donor and two policymakers) did not participate;
one declined and two were not available. The inter-
viewees represented five categories as no national private
sector actor was identified or interviewed. However, this
perspective was later captured informally through dis-
cussions with a representative of Vestergaard Frandsen.
We present findings according to the analytical frame-
work themes, including one sub-theme that emerged
during interviewing, i.e. the classification of forms of
power. Within each theme, we highlight barriers and op-
portunities for accelerated access to next-generation
LLINs in Burkina Faso. Additional quotes to support the
themes are presented in Additional file 3.
Policymaking context
In Burkina Faso, the entire population is at risk of mal-
aria. In 2013, there were approximately 3.7 million re-
ported confirmed malaria cases and over 6000 deaths
[23]. Malaria accounts for 50 % of all outpatient consul-
tations, 57 % of hospitalisations and 46 % of deaths [24].
At the national level, the MoH (Ministère de la Santé),
through the PNLP, is responsible for all health policy
and strategy development, partner coordination and re-
source mobilisation [25, 26]. The regional and peripheral
levels focus primarily on implementation activities.
As one of the world’s poorest countries [27], Burkina
Faso is reliant on external organisations to finance most
aspects of its malaria control interventions. In 2011, over
US$ 70.6 million was spent controlling malaria [28],
68 % of which was provided by GFATM, 15 % by United
States Agency for International Development (USAID),
and about 12 % by the government [28]. Figure 1 shows
the breakdown of 2011 expenditure on malaria control
by funding source.
In 2010, almost 8 million LLINs were distributed na-
tionwide, 88.9 % were financed by GFATM through two
funding rounds 7 and 8. Other sources of LLINs include
those procured using donor basket funds by PADS
(6.9 %) and by USAID (1.7 %), International Federation
of Red Cross and Red Crescent societies (1.7 %), and
UNICEF (1.3 %).1 Figure 2 shows the sources of support
for LLINs in the 2010 LLIN nationwide distribution
campaigns. In 2013, GFATM financed over 90 % of the
LLINs distributed.
National vector control policy content
The overall goal of the Burkina Faso National Malaria
Strategic Plan 2011–2015 is to reduce malaria morbidity
by 75 %, compared to 2010 levels, and malaria mortality
to a level close to zero by the end of 2015 [28]. Table 2
summarises the vector control objectives in the Strategic
Plan [28], the coverage of interventions of populations at
risk as at 2012 [29] and the revised national objectives as
of March 2014. In line with WHO recommendations,
one objective is to achieve and maintain 100 % of the
population sleeping under a LLIN by the end of 2015.
Policymaking actors
The interviewees identified actors involved in policy-
making as the MoH and its technical departments such as
PNLP; other ministries such as those for finance, commu-
nications and environment; research centres, including
Fig. 1 Sources of 2011 malaria control funding in Burkina Faso
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the Centre National de Recherche et de Formation sur le
Paludisme and Centre Muraz; technical and financial part-
ners, including WHO, GFATM, UNICEF, USAID, Inter-
national Federation of Red Cross and Red Crescent
societies and PLAN Burkina.
All interviewees recognised the central role of the Comité
National de Pilotage de la Lutte Contre le Paludisme
(Comité de Pilotage), the national steering committee for
malaria, in supporting PNLP in delivering its mandate.
The Comité de Pilotage is composed of five commissions,
including one focused on vector control. The main re-
sponsibilities of the vector control commission are to
make recommendations to PNLP in defining vector con-
trol strategies, support the development and revision of
guidance documents, monitor the implementation of vector
control activities, and monitor insecticide resistance [30].
The interviewees and the terms of reference of the
Comité de Pilotage [30] outlined four main groups of ac-
tors and the roles that they played in the policymaking
process (Fig. 3).
(i) Researchers: Four national research centres conduct
malaria research across the country. Data generated
feeds in to the national policymaking process
through the MoH and Comité de Pilotage [25, 31].
However, interviewees, particularly researchers,
multilaterals and donors, outlined that, while local
research/researchers are valuable, there is a need to
Fig. 2 Funding source for LLINs distributed in 2010
Table 2 Original and revised vector control policy objectives in Burkina Faso’s National Malaria Control Strategic Plan
Vector control objectives in the 2011–2015
strategic plan [28]
Progress towards target in
Burkina Faso as of 2012 [29]
Revised vector control
objectives 2014 [28]
2014 Malaria Indicator Survey Results [16]
1 100 % of the population sleeping under
long-lasting insecticide-treated nets (LLINs)
Approximately 50 % of
total population at risk
Achieve and maintain
100 % coverage
71 % of the households have access to at
least one LLIN
In households with at least one LLIN, 74 %
of the population of these
Households slept under mosquito nets
at night
2 100 % of the populations of the four health
regions targeted (South-West, Cascades,
Hauts-basins and Mouhoun) benefit from
indoor residual spraying (IRS)
Approximately 1 % of
population covered
Suspension of IRS
3 100 % of the targeted breeding sites in the
Central and Hauts-Bassins regions are
covered by larviciding
No data Extension of larviciding to
Bobo-Dioulasso region
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collaborate with international research institutions
to strengthen the credibility of research outputs.
‘Even if a research is made in Burkina Faso, if the
signature is international it means that you have done
it in collaboration with an international institute, this
is very important. That is because in the eyes of
donors, the international character is of great value’
(policymaker)
(ii)Technical and financial partners: Multilaterals,
donor and NGOs are collectively known as technical
and financial partners. They provide technical advice
and financial input to the policy development and
implementation.
‘The TFP [Technical and Financial Partners] …., they
have money and they have the ideas, knowledge. Ok?
Money and knowledge’ (researcher)
(iii) Policymakers: Interviewees considered policymakers
to be the technicians that drafted the policies and
the decision-makers who ratified these.
(iv) Technicians: All interviewees recognised PNLP as
the ‘technician’ who drafts the policy document
coordinating inputs from researchers, the technical
advisers and other stakeholders.
‘Technical departments are really conducting daily
follow-up-evaluation of the Programmes, which lead to
new information which requires that a policy be
changed. They also give a technical draft to the Office
of the Ministry of Health where they decide on what
needs to be done’ (researcher)
(v)Decision-makers: All interviewees recognised the
role of the national government through the MoH
and the cabinet to make final decisions on ratifying
policies that had been drafted by the technicians.
‘…but now when the policy goes for decision making, the
decision is taken at another level that I called
politicians; when I say politicians. I mean the ministries,
the Parliament who approve policies’ (NGO)
Perceptions of power
Power was observed when interviewees identified the ac-
tors they thought carried the most influence and when
interviewees described the roles various actors played in
the policymaking process.
Fig. 3 Actor and their roles in national policy making
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Interviewees identified different forms of power:
(i) Power as decision-making: This dimension of power
was expressed as the national government’s ability to
endorse or reject a policy.
‘As a technician you can write policies, write strategies
that are relevant enough according to you; and they
will go to the highest level for decision making, that’s
something else. Those at the highest level will decide
on whether they are going for this policy or not’ (NGO)
(ii)Power to influence opinion: WHO was viewed as an
important actor as its recommendations influenced
national policy content and direct what donors will
support, thereby mediating actor’s (e.g. PNLPs)
options when drafting policy documents. National
researchers also saw themselves as having a role
(and to some extent influence) in contributing to the
global evidence base, which in turn influences WHO
recommendations.
‘If the WHO recommends something, tomorrow you
will see that people put it in application very quickly’
(policymaker)
(iii) Financial power: All interviewees cited financial
resources as being the most powerful reason for
policy adoption. Consequently, GFATM who funds
most of malaria control in Burkina Faso was
perceived as the most influential actor [28].
‘The Global Fund plays the most important role
because the Global Fund is financing the malaria
control programme by 80%. So for many policies
concerning malaria control, the Global Fund
influences much even if it is not making [the] decision
all alone’ (donor)
Although donors were viewed to possess a great degree
of power, their power was not absolute. All interviewees
recognised WHO recommendations’ influence over policy
content and donor funding and two interviewees viewed
decision-makers to be the most powerful actors.
Policy adoption process
Interviewees recognised that the first step in the policy
adoption of a new vector control tool would be inter-
national endorsement/recommendation of the tool.
‘First step in [the] adoption process is the international
adoption of the product..… If Burkina Faso wants to
adopt a new policy, first of all that policy must be
proved internationally’ (NGO)
The PNLP draft the policy document with input from
the partners in the Comité de Pilotage, acting in an ad-
visory capacity. The policy is then submitted to the
MoH and the national assembly for endorsement.
‘The country adopts; when I say the country adopts I
mean the coordinator of the national programme of
malaria control must prepare the case file and submit
to the hierarchy. That is to say, the directorate of
disease control, the General Directorate of Health, the
General Secretariat, and the Ministry. Now, if it is
accepted, it becomes part of the policy’ (policymaker)
A donor’s willingness to finance was perceived to be
one of the most powerful incentives for policy adoption.
‘Locally here what I’m saying is just come with your
resources saying that you have money to support such
strategy, it will be accepted’ (researcher)
All interviewees expressed a certain level of pointless-
ness in going through the adoption process without glo-
bal adoption and funding already being in place.
‘The government has very few resources to put in, so
resources are coming usually from the donors. They
[donors] want to have it approved by the WHO first
before putting their money. So meaning that you can
have a very nice and promising result, but you need to
put in place a lobby group just to push it and get it
approved internationally before coming back’
(researcher)
Figure 4 outlines the policy adoption process as de-
scribed by interviewees showing that the genesis of the
national policy process is at the global level.
The role of evidence in vector control policymaking
There are strong formalised relationships between research
centres, the MoH and Comité de Pilotage, with clear chan-
nels for communicating research results to key policy-
makers within the MoH and the wider stakeholders [31].
‘At national level, you have the research institutions
who will, based on the new findings, just report by
[MoH] hierarchy which also transfer these findings to
the Comité de Pilotage’ (researcher)
While this should foster increased use of research in
policymaking, as described above, nationally generated
research was perceived to have limited impact on policy.
‘Nationally here you have a very nice result, but after
you finish, you close your reports, you publish, you go
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and report, nobody is talking about it. You have to
wait to get it approved internationally and now it
comes back’ (researcher)
In this context, it is worth noting that PermaNet© 3.0
was evaluated in Burkina Faso using WHOPES protocols
and included in a publication describing the results of a
similar trial from multiple settings [32].
Availability
Five brands of LLINs were distributed in 2010: Interceptor©,
Dawa plus©, PermaNet© (including PermaNet 2.0 and
3.0), Netprotect© and Olyset© net [14]. When interviewees
were asked about factors influencing availability (choosing
and procuring LLINs), a number of issues came to light.
Firstly, the primary factor determining LLIN availabil-
ity is WHOPES recommendation.
‘A decision maker before accepting a brand of nets
must make sure that it is a net that is recognised by
the WHO; and accepted in line with WHOPES
standards’ (NGO)
Secondly, in line with the perceptions on the import-
ance of financial power, all interviewees noted that, for
current and future vector control tools, such as next-
generation LLINs, price would be a key factor in deter-
mining availability.
‘Alright, money is the issue because even the Global
Fund is considering the price. When you want to buy
mosquito nets through the Global Fund you cannot
budget for any mosquito net which costs 5 or 6
dollars each because the Global Fund could buy at 2
or 3 dollars each if they need a huge quantity of it.
So the Global Fund will not accept those prices’
(multilateral)
The factors influencing the decision to distribute a
PBO LLIN (PermaNet© 3.0) were explored. A few inter-
viewees were aware that PermaNet© 3.0 had been dis-
tributed but none were aware of what influenced the
decision to purchase and distribute them.
‘They provided us with that product [PermaNet© 3.0],
there’s no criteria on which we can ourselves choose
PermaNet 3.0 just because we think resistance is lower
with it than other products’ (policymaker)
The decision to distribute PermaNet© 3.0 appeared to
be based on price and actions of international/external
actors, i.e. net manufacturers.
‘[I was] not aware of the decision, [it] looks like it was
taken outside. The materials [PermaNet© 3.0] were
ordered by an external body and sent to the country’
(researcher)
Currently, once approved by WHOPES, all brands and
types of LLINs (including PBO LLINs) are considered
the same. Therefore, country decisions focus on articu-
lating specifications (physical characteristics, insecticide,
binding process, dimensions etc.) to the relevant pro-
curement department. This choice can be influenced by
a desire to stick to tried and tested products or a protec-
tion of individual interests. Taken in the context of the
counterfeit nets distributed in 2010, comments made by
some interviewees have added significance. They seem
to confirm that some actors were aware of the fraud and
of the potential for high value contracts to be misman-
aged for personal financial gain.
‘So people are afraid of the unknown, they fear
anything which is new, they think the other tools are
already effective, and then they limit themselves to the
Fig. 4 National policy adoption process for a new vector control tool
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old tools, but most often it is because some people
have their own interests [claps] because if they import
nets, they know what it’s worth. People have their own
deal in the contract. It is the same people who
awarded the mosquito net contracts in 2010 to their
friends that we all we know.’ (NGO)
It is worth noting that nets distributed in 2013 were
procured through the GFATM voluntary pooled pro-
curement system. Recognising weaknesses in their own
practices, GFATM have also initiated a number of im-
provements including pre-shipment testing of nets,
greater oversight of bidders’ relevant experience and the
appropriateness of tender specifications, and are seeking
to recover funds from those implicated in the counter-
feiting [19].
Affordability
In Burkina Faso, the affordability of LLINs effectively
means the willingness of international donors to finance
it, which in turn is influenced by global recommendations.
‘If the WHO approves the new tool, I believe that
international initiatives will agree to finance the tool
and I’m sure it will become more accessible’
(policymaker)
Cost was viewed as a major influence on donors’ will-
ingness to finance, with one interviewee citing the case
of IRS being halted due to its relatively high cost.
‘There is not only the issue of effectiveness but also the
problem of cost. Why is it that the indoor spraying
which is very effective is unfortunately stopped?
Because it is very expensive! It is so expensive that we
cannot afford it’ (multilateral)
A barrier to affordability, raised by all interviewees, is
the need to meet set targets, which is jeopardised if the
new tool is more expensive and the funding envelope re-
mains fixed.
‘You have set amount of money but still need to
achieve universal coverage. While your target remains
universal coverage because you have signed up the
Abuja declaration if you want to buy more expensive
nets you will have to find additional funds.’
(multilateral)
Just one interviewee raised the issue of differences in
performance between net types.
‘Now they need to show us the methods that allow us
to have more impact, The Global Fund is naturally
interested in the impact, the efficiency and the
effectiveness, and we will not get away too much from
the prescribed actions at the international level in
relation to a resistance that occurred, this for sure.’
(donor)
Interviewees highlighted that an opportunity for im-
proving availability and affordability would be more in-
dependence from international funding in the form of
allocation of national funds to malaria control.
‘So the first issue would be just trying to work with the
policymakers to allocate resources for their own policy
instead of just waiting for resources coming
somewhere’ (researcher)
Discussion
Case studies have proven to be an effective method in
exploring real-life policy events [33, 34], including exam-
ining gaps in access to drugs [35], the development of
family planning programmes [36] and the coordination
of donor aid policies in developing countries [37]. In
Burkina Faso, much of the national policy analysis in the
malaria field has focused on the adoption of artemisinin-
based combination therapy and home-based manage-
ment of malaria [31, 38–40]. However, Burkina Faso
appears amenable to the timely translation of global
guidance on malaria control into national policy; being
one of the first countries to adopt intermittent prevent-
ive treatment for infants and seasonal malaria chemo-
prevention [29].
This is the first time the Frost and Reich framework
has been used to analyse national malaria vector control
policymaking in Burkina Faso. The framework and its
elements, when combined with those of the Walt and
Gilson framework [20], are suitable for national level
policymaking analysis (recognising that sub-national fac-
tors, while important, were beyond the scope of the
present study) and all responses fitted into the themes
contained within the framework. However, the different
dimensions of power and the different categories of pol-
icy actors are nuances within existing themes that
emerged during the interviews.
A strong framework of actors linked to research cen-
tres has been identified as one of the key strengths of
malaria control in Burkina Faso [28]. Burkina Faso has a
strong track record of malaria vector control research
with two internationally recognised research groups;
they are at the forefront of insecticide resistance re-
search with in excess of 14 publications with Burkinabe
first authors on this topic in the past 10 years. More re-
cently, a Burkina-based study was one of the first to
demonstrate that standard LLIN effectiveness is compro-
mised by insecticide resistance [14]. Despite this, the
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researchers interviewed felt that the ability for their out-
puts to influence national policy was dependent on col-
laboration with international researchers.
While not mentioned by any interviewees, the desk re-
view showed that WHO’s Evidence Informed Policy Net-
work (EVIPNet) in Burkina Faso (consisting of Burkinabe
policymakers and researchers) has successfully supported
evidence-based policymaking on wide-scale access to
artemisinin-based combination therapies and has been
pivotal in getting this funded by the GFATM [39, 41].
This study identified three dimensions of power. While
only the government had power over which policies were
endorsed, this was limited by its relatively low financial
power. Conversely, those with financial power, such as the
GFATM, are limited by the commitment to only support
tools endorsed by WHO. While no actors were seen to
have absolute power, financial resources conferred signifi-
cant power on those that fund vector control. This is cap-
tured by the interviewees’ perception that it is futile to
adopt a policy without financial backing. This finding is
consistent with studies that have observed the potential
for new funding to change the policymaking landscape
[40] and push through policy adoption [42]. In a country
like Burkina Faso, where financial power is concentrated
in the hands of one institution (GFATM), the potential for
scaling-up access to a new tool is tied to their willingness
to finance it. This is in contrast to studies that show in-
stances of policies being driven by actors involved in its
implementation (bottom up approach) [43, 44]. This con-
trast is not surprising given that the LLINs are predomin-
ately delivered and financed from top down [5].
This study highlights the need for increased domestic
funding for malaria control commodities [26] to reduce
donor dependence [45] and increase the power of policy-
makers in Burkina Faso to choose appropriate interven-
tions for their setting. Other studies have demonstrated
the potential for high-level global subsidies to improve the
availability of affordable high quality malaria control inter-
ventions [46]. This may be something that needs to be
considered if the new vector control tools replacing those
whose efficacy is being eroded by resistance have a higher
unit cost.
The GFATM new funding model is a potential oppor-
tunity to improve access to new malaria control tools
like next-generation LLINs. The new funding model di-
rects up-front allocations, aligned to national strategic
priorities [47]. Thus, a country like Burkina Faso would
be able to make a case for the purchase of next-
generation LLINs using GFATM resources, even where
these are more expensive, if it were able to document re-
ductions in the effectiveness of standard LLINs and
greater effectiveness of new tools.
Vector control policymaking in Burkina Faso is largely
based on policy transfer, i.e. policy ideas from one space
and time influencing another [22]. The national policy
process is well defined but is dependent on global mal-
aria policymaking and available resources. Despite the
recognition by the Vector Control Advisory Group of
potential additional benefit of PBO LLINs against in-
secticide resistant mosquitoes [11], at the time the study
was conducted, there was no WHO guidance on where
and when next-generation LLINs might positively im-
pact on malaria transmission, severely limiting their abil-
ity to be adopted at the national level and financed by
the main donors. In December 2015, WHO Global Mal-
aria Programme released recommendations on conditions
for use of LLINs treated with PBO [48]. It recognised that
PBO LLINs have increased efficacy in certain settings but
argued that the evidence was too limited to justify a
complete switch to PBO nets in all settings. It is evident
that a switch from conventional LLINs to PBO LLINs
would not be appropriate in all settings as, in areas where
mosquito populations remain susceptible to pyrethroids,
there is no rationale to implement a product that is likely
to have a higher unit cost. However, rather than provide
guidelines on when and where a switch to PBO LLINs
may be justified, WHO recommends pilot exploratory im-
plementation with robust monitoring and evaluation [48].
Nevertheless, it also states that PBO LLINs should ‘only be
used where universal coverage […] will not be reduced’,
which means that pilot studies are only likely to be pos-
sible where PBO nets are provided free of charge or at the
same price as standard LLINs.
Donor policies only permit WHOPES-recommended
LLINs [49, 50] with countries having little control over
the net selection. As WHOPES do not currently distin-
guish between PBO and conventional LLINs, the potential
to tackle resistance is not part of the decision-making
process in LLIN procurement in Burkina Faso. In Burkina
Faso, interviewees confirmed that the donor’s procure-
ment department or agent oversaw the competitive bid-
ding process where the ‘cheapest’ LLIN was bought.
Vestergaard Frandsen, the manufacturers of PermaNet©
3.0, have since confirmed that it was offered at a ‘competi-
tive price’ in Burkina Faso to ensure they were used in the
right context (H Pates Jamet, Vestergaard Frandsen, per-
sonal communication).
The price of a next-generation LLIN was viewed by in-
terviewees as the single most important factor in deter-
mining its affordability (i.e. willingness to purchase).
This was linked to donors’ desire to get the highest LLIN
coverage for a given level of expenditure which, in turn,
stems from global and national targets for universal
coverage with LLINs. While not suggesting that these tar-
gets should be abandoned, it is important to review them
in light of the potential for insecticide resistance to reduce
LLIN performance. In the absence of a clear recommen-
dation of when and where to target next-generation
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LLINs, countries may be left deploying LLINs that are less
effective in areas with insecticide resistance to meet cover-
age targets at the expense of potentially more effective
solutions.
The benefits of PBO LLINs, which can be up to US$ 2.30
more expensive than standard LLINs [12], might be clearer
if donors and national programmes incorporated impact
measures (overall reduction in transmission) into procure-
ment decisions and focussed on the cost-effectiveness of
alternative tools (as opposed to unit cost). In order for this
to make a difference, evidence-based global recommenda-
tions on when and where next-generation LLINs are likely
to provide the greatest protection, and the likely magni-
tude of this effect, are urgently required. The current ab-
sence of global guidance on the role and cost-effectiveness
of next-generation LLINs in vector control in countries
with insecticide resistance is a critical barrier to donor
funding and national adoption of next-generation LLINs.
Limitations
The findings from this study confirm that national and
global levels of policymaking are interlinked. In a follow
on study we look at this question is addressed from a
global policymaking perspective. Although participants
did not identify the private sector as key to decision-
making, it may have been beneficial to have included a
perspective from a manufacturer of a next-generation
LLIN as opposed to directing specific questions to a repre-
sentative of this sector after the interviews were complete.
The problem of counterfeit nets, confirmed after the inter-
views had been conducted, could have limited the willing-
ness of respondents to openly discuss LLIN procurement;
however, some respondents alluded to this and hence
these perspectives were captured. Finally, the researcher’s
ability to be the primary data collector was limited due to
language barriers and the reduced access given to re-
searchers considered ‘outsiders’ [34]. However, this limita-
tion provided an advantage in the data analysis process
where an outsider status conferred objectivity in the inter-
pretation of results. Mr Traore is a Burkinabe working at
the Centre National de Recherche et de Formation sur le
Paludisme and therefore has some level of insider status
[34], allowing for additional insight into the cultural con-
text and helping establish rapport with interviewees dur-
ing data collection.
Conclusions
This study shows that access to next-generation LLINs
was severely compromised by the lack of global guidance
on where and when they should be deployed. In a coun-
try like Burkina Faso, where WHO recommendations
are relatively quickly adopted, a clear WHO recommen-
dation is the key to unlocking financial resources for and
accelerating access to next-generation LLINs. It remains
to be seen whether the December 2015 WHO recom-
mendation will impact on access to these products.
Furthermore, evidence collected by national research in-
stitutions on insecticide resistance should be extended to
monitor (changes in) effectiveness of standard LLINs. As
well as supporting evidence-based national policymaking,
these data should be given greater credence in funding ap-
plications to key donors and in global policymaking.
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